Latest revenue
$11.8M
as of 2026-04-04
Latest net income
$-524.0K
as of 2026-04-04
Net margin
-4.4%
as of 2026-04-04
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $17.6M
- Enterprise value
- $17.6M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $1.65
- 52-wk low
- $0.87
- Beta
- —
- Shares out
- 17.4M
5-year trend
About IRIX
Business description and risk factors will appear here once IRIX's latest filing is fully ingested.
Profitability
Gross margin
36.5%
8.9%Operating margin
-4.9%
71.4%Net margin
-8.4%
54.0%Return on equity
-211.6%
50.2%Return on assets
-15.2%
50.2%Leverage
Debt / equity
12.90×
0.1%Long-term debt / equity
1.78×
272.0%Debt / assets
92.8%
0.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q2 2026 2026-04-04 | $11.8M | -0.8% | $-524.0K | +68.9% | -4.4% |
Q1 2026 2026-01-03 | $14.7M | +16.0% | $-184.0K | +77.9% | -1.2% |
Q3 2025 2025-09-27 | $12.5M | +7.8% | $-1.6M | +18.6% | -12.6% |
Q2 2025 2025-06-28 | $13.6M | +7.4% | $-994.0K | +62.9% | -7.3% |
Q1 2025 2025-03-29 | $11.9M | +1.1% | $-1.7M | +51.3% | -14.2% |
Q4 2024 2024-12-28 | $12.7M | — | $-834.0K | — | -6.6% |
Q3 2024 2024-09-28 | $11.6M | -9.9% | $-1.9M | -10.2% | -16.7% |
Q2 2024 2024-06-29 | $12.6M | -1.7% | $-2.7M | +3.1% | -21.2% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Electromedical & Electrotherapeutic Apparatus · SIC 3845
Your notes
Keep private notes on IRIX — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$216.6K
Insider selling
$0
Net activity
+$216.6K
Distinct insiders
3
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns IRIX
Institutional value
$1.1M
Total shares held
1.1M
Distinct holders
13
-9 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 514.6K | $519.7K | — | New |
| 2 | WEBER CAPITAL MANAGEMENT LLC /ADV | 259.6K | $262.2K | +0 (+0.0%) | No change |
| 3 | VANGUARD FIDUCIARY TRUST CO | 60.2K | $60.8K | — | New |
| 4 | PERKINS CAPITAL MANAGEMENT INC | 55.3K | $55.9K | +14.0K (+33.9%) | Added |
| 5 | THOMPSON DAVIS & CO., INC. | 47.4K | $47.9K | +18.9K (+66.5%) | Added |
| 6 | JANE STREET GROUP, LLC | 37.6K | $38.0K | +5.9K (+18.5%) | Added |
| 7 | DIVERSIFY WEALTH MANAGEMENT, LLC | 33.8K | $34.9K | — | New |
| 8 | Bank of New York Mellon Corp | 25.6K | $25.9K | -5.9K (-18.7%) | Trimmed |
| 9 | BlackRock, Inc. | 20.3K | $20.5K | +0 (+0.0%) | No change |
| 10 | HighTower Advisors, LLC | 10.0K | $10.1K | +0 (+0.0%) | No change |
| 11 | Vanguard Global Advisers, LLC | 4.0K | $4.0K | — | New |
| 12 | UBS Group AG | 1.1K | $1.2K | — | New |
| 13 | GROUP ONE TRADING LLC | 1.1K | $1.1K | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once IRIX's latest filing finishes processing.